Why are they delaying the release until tomorrow? We know they aren't hitting the $2.4m receipts they projected last quarter. Best case, we can expect around $1.2m-$1.5m. Most likely due to timing, they will report less.
What I hope to see though is a drop in variable costs. I keep on mentioning this but operating expenses have always been high for very little production. I don't quite understand that..
- Forums
- ASX - By Stock
- ELE
- Ann: Operational Update Phase 3 Acceleration
Ann: Operational Update Phase 3 Acceleration, page-54
Featured News
Add ELE (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Will Souter, CFO
Will Souter
CFO
Previous Video
Next Video
SPONSORED BY The Market Online